Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1997 Jul 29;352(1355):763–770. doi: 10.1098/rstb.1997.0060

Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?

D R Bainbridge 1, M W Lowdell 1, I M Hannet 1, K W Strauss 1, A Karpas 1
PMCID: PMC1691967  PMID: 9279896

Abstract

Healthy HIV-positive regular donors of plasma in a programme of passive immunotherapy for AIDS patients were studied over a period of about two years. None developed symptoms of clinical progression; most seemed to make substantial gains of CD4 cells by comparison with asymptomatic individuals who were not donating. The effects of donation did not seem to diminish with repetition, and donor CD4 counts tended towards stabilizing within normal limits. Asymptomatic HIV-positive individuals were compared immunologically with 'normals' and people with AIDS, using a battery of 25 measurements on peripheral blood. The immunological profiles of donor and non-donor asymptomatics, indistinguishable at the start, became dissimilar: donors' profiles resembled AIDS less, non-donors became less like 'normal' and a few non-donor results could not be distinguished from AIDS. Improvement in the CD4 counts and amelioration of the immunological profile in donors provide prima facie evidence that plasmapheresis may be therapeutic for asymptomatic HIV-positive people. Further studies are justified.

Full Text

The Full Text of this article is available as a PDF (598.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aledort L. M., Hilgartner M. W., Pike M. C., Gjerset G. F., Koerper M. A., Lian E. Y., Lusher J. M., Mosley J. W. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. BMJ. 1992 Jan 25;304(6821):212–216. doi: 10.1136/bmj.304.6821.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen C. H., Weinhold K. J., Bartlett J. A., Bolognesi D. P., Greenberg M. L. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses. 1993 Nov;9(11):1079–1086. doi: 10.1089/aid.1993.9.1079. [DOI] [PubMed] [Google Scholar]
  3. Choi S., Lagakos S. W., Schooley R. T., Volberding P. A. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med. 1993 May 1;118(9):674–680. doi: 10.7326/0003-4819-118-9-199305010-00003. [DOI] [PubMed] [Google Scholar]
  4. Coffin J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995 Jan 27;267(5197):483–489. doi: 10.1126/science.7824947. [DOI] [PubMed] [Google Scholar]
  5. Cummins L. M., Weinhold K. J., Matthews T. J., Langlois A. J., Perno C. F., Condie R. M., Allain J. P. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Blood. 1991 Mar 1;77(5):1111–1117. [PubMed] [Google Scholar]
  6. De Wolf F., Roos M., Lange J. M., Houweling J. T., Coutinho R. A., van der Noordaa J., Schellekens P. T., Goudsmit J. Decline in CD4+ cell numbers reflects increase in HIV-1 replication. AIDS Res Hum Retroviruses. 1988 Dec;4(6):433–440. doi: 10.1089/aid.1988.4.433. [DOI] [PubMed] [Google Scholar]
  7. Easterbrook P. J., Emami J., Gazzard B. Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients. AIDS. 1993 Oct;7(10):959–967. [PubMed] [Google Scholar]
  8. Ellenberg S. S. Surrogate end points in clinical trials. BMJ. 1991 Jan 12;302(6768):63–64. doi: 10.1136/bmj.302.6768.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erkeller-Yuksel F. M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., Mackinnon H., Stokes L. T., Munhyeshuli V., Vanlangendonck F. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992 Feb;120(2 Pt 1):216–222. doi: 10.1016/s0022-3476(05)80430-5. [DOI] [PubMed] [Google Scholar]
  10. FREEMAN G. H., HALTON J. H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951 Jun;38(1-2):141–149. [PubMed] [Google Scholar]
  11. Ferbas J., Kaplan A. H., Hausner M. A., Hultin L. E., Matud J. L., Liu Z., Panicali D. L., Nerng-Ho H., Detels R., Giorgi J. V. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis. 1995 Aug;172(2):329–339. doi: 10.1093/infdis/172.2.329. [DOI] [PubMed] [Google Scholar]
  12. Graham N. M., Piantadosi S., Park L. P., Phair J. P., Rinaldo C. R., Fahey J. L. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. J Acquir Immune Defic Syndr. 1993 Nov;6(11):1258–1266. [PubMed] [Google Scholar]
  13. Hulstaert F., Hannet I., Deneys V., Munhyeshuli V., Reichert T., De Bruyere M., Strauss K. Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol. 1994 Feb;70(2):152–158. doi: 10.1006/clin.1994.1023. [DOI] [PubMed] [Google Scholar]
  14. Karpas A., Gillson W., Bevan P. C., Oates J. K. Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies. Lancet. 1985 Sep 28;2(8457):695–697. doi: 10.1016/s0140-6736(85)92934-4. [DOI] [PubMed] [Google Scholar]
  15. Karpas A., Gray J., Byron N., Gilgen D., Bally V., Oates J. K., Gazzard B. Passive immunization in ARC and AIDS. Biotherapy. 1990;2(2):159–172. doi: 10.1007/BF02173455. [DOI] [PubMed] [Google Scholar]
  16. Karpas A., Hewlett I. K., Hill F., Gray J., Byron N., Gilgen D., Bally V., Oates J. K., Gazzard B., Epstein J. E. Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7613–7617. doi: 10.1073/pnas.87.19.7613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Karpas A., Hill F., Youle M., Cullen V., Gray J., Byron N., Hayhoe F., Tenant-Flowers M., Howard L., Gilgen D. Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9234–9237. doi: 10.1073/pnas.85.23.9234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kundu S. K., Merigan T. C. Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection. Immunology. 1991 Dec;74(4):567–571. [PMC free article] [PubMed] [Google Scholar]
  19. Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J. J., Bach B. A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol. 1992 Dec;90(3):376–382. doi: 10.1111/j.1365-2249.1992.tb05854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levy J., Youvan T., Lee M. L. Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double-blind controlled trial. The Passive Hyperimmune Therapy Study Group. Blood. 1994 Oct 1;84(7):2130–2135. [PubMed] [Google Scholar]
  21. Mackewicz C. E., Ortega H., Levy J. A. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol. 1994 Feb;153(2):329–343. doi: 10.1006/cimm.1994.1032. [DOI] [PubMed] [Google Scholar]
  22. Mihailov C., Lamour A., Beaudré-Bellein V., Jézequel N., Garré M., Mottier D., Guillet G., Youinou P. Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus. J Clin Immunol. 1993 Mar;13(2):139–144. doi: 10.1007/BF00919270. [DOI] [PubMed] [Google Scholar]
  23. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Muñoz A., Carey V., Saah A. J., Phair J. P., Kingsley L. A., Fahey J. L., Ginzburg H. M., Polk B. F. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1988;1(4):396–404. [PubMed] [Google Scholar]
  25. Phillips A. N., Lee C. A., Elford J., Janossy G., Timms A., Bofill M., Kernoff P. B. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991 Feb 16;337(8738):389–392. doi: 10.1016/0140-6736(91)91166-r. [DOI] [PubMed] [Google Scholar]
  26. Phillips A., Lee C. A., Elford J., Janossy G., Bofill M., Timms A., Kernoff P. B. Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. AIDS. 1989 Nov;3(11):737–741. doi: 10.1097/00002030-198911000-00008. [DOI] [PubMed] [Google Scholar]
  27. Quint L., Autran B., Guillon J. M., Parrot A., Denis M., Debre P., Mayaud C. M., Akoun G. M. Alvéolites lymphocytaires aux stades précoces de l'infection par le VIH: corrélations avec les facteurs biologiques de pronostic. Rev Mal Respir. 1992;9(2):155–162. [PubMed] [Google Scholar]
  28. Sheppard H. W., Lang W., Ascher M. S., Vittinghoff E., Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS. 1993 Sep;7(9):1159–1166. [PubMed] [Google Scholar]
  29. Vittecoq D., Chevret S., Morand-Joubert L., Heshmati F., Audat F., Bary M., Dusautoir T., Bismuth A., Viard J. P., Barré-Sinoussi F. Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1195–1199. doi: 10.1073/pnas.92.4.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vittecoq D., Mattlinger B., Barre-Sinoussi F., Courouce A. M., Rouzioux C., Doinel C., Bary M., Viard J. P., Bach J. F., Rouger P. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis. 1992 Feb;165(2):364–368. doi: 10.1093/infdis/165.2.364. [DOI] [PubMed] [Google Scholar]
  31. Walker C. M., Moody D. J., Stites D. P., Levy J. A. CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cell Immunol. 1989 Apr 1;119(2):470–475. doi: 10.1016/0008-8749(89)90259-1. [DOI] [PubMed] [Google Scholar]
  32. Walker C. M., Moody D. J., Stites D. P., Levy J. A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986 Dec 19;234(4783):1563–1566. doi: 10.1126/science.2431484. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES